New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy

References

• Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide. IARC CancerBase No. 11 [Internet] Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr
   Google Scholar
• Surveillance, Epidemiology, and End Results (SEER) Program. National Cancer Institute, DCCPS, Cancer Statistics Branch 2011. Available from: www.seer.cancer.gov [updated based on the November 2010 submission]
   Google Scholar
• Surveillance, Epidemiology, and End Results (SEER) Program Populations (1969-2009). National Cancer Institute, DCCPS, Cancer Statistics Branch 2011. Available from: www.seer.cancer.gov/popdata
   Google Scholar
• Chihara D, Ito H, Matsuda T, et al. Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol 2014;164(4):536-45
   PubMed Web of Science ®Google Scholar
• Sant M, Allemani C, Tereanu C, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 2010;116(19):3724-34
   PubMed Web of Science ®Google Scholar
• Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006;107(1):265-76
   PubMed Web of Science ®Google Scholar
• Kane EV, Bernstein L, Bracci PM, et al. Postmenopausal hormone therapy and non-Hodgkin lymphoma: a pooled analysis of InterLymph case-control studies. Ann Oncol 2013;24(2):433-41
   PubMedGoogle Scholar
• Kamper-Jorgensen M, Rostgaard K, Glaser SL, et al. Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the international lymphoma epidemiology consortium (InterLymph). Ann Oncol 2013;24(9):2245-55
   PubMedGoogle Scholar
• Gibson TM, Smedby KE, Skibola CF, et al. Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium. Cancer Causes Control 2013;24(1):125-34
   PubMedGoogle Scholar
• Cocco P, Vermeulen R, Flore V, et al. Occupational exposure to trichloroethylene and risk of non-Hodgkin lymphoma and its major subtypes: a pooled InterLymph [correction of IinterLlymph] analysis. Occup Environ Med 2013;70(11):795-802
   PubMedGoogle Scholar
• Nieters A, Conde L, Slager SL, et al. PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium. Blood 2012;120(23):4645-8
   PubMedGoogle Scholar
• Kane EV, Roman E, Becker N, et al. Menstrual and reproductive factors, and hormonal contraception use: associations with non-Hodgkin lymphoma in a pooled analysis of InterLymph case-control studies. Ann Oncol 2012;23(9):2362-74
   PubMedGoogle Scholar
• Turner JJ, Morton LM, Linet MS, et al. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood 2010;116(20):e90-8
   PubMed Web of Science ®Google Scholar
• Skibola CF, Bracci PM, Nieters A, et al. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol 2010;171(3):267-76
   PubMed Web of Science ®Google Scholar
• Vajdic CM, Falster MO, de Sanjose S, et al. Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res 2009;69(16):6482-9
   PubMed Web of Science ®Google Scholar
• Willett EV, Morton LM, Hartge P, et al. Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer 2008;122(9):2062-70
   PubMed Web of Science ®Google Scholar
• Kricker A, Armstrong BK, Hughes AM, et al. Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer 2008;122(1):144-54
   PubMed Web of Science ®Google Scholar
• Ekstrom Smedby K, Vajdic CM, Falster M, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 2008;111(8):4029-38
   PubMed Web of Science ®Google Scholar
• Wang SS, Slager SL, Brennan P, et al. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the international lymphoma epidemiology consortium (InterLymph). Blood 2007;109(8):3479-88
   PubMed Web of Science ®Google Scholar
• Morton LM, Turner JJ, Cerhan JR, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the pathology working group of the international lymphoma epidemiology consortium (InterLymph). Blood 2007;110(2):695-708
   PubMed Web of Science ®Google Scholar
• Rothman N, Skibola CF, Wang SS, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 2006;7(1):27-38
   PubMedGoogle Scholar
• Morton LM, Hartge P, Holford TR, et al. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the international lymphoma epidemiology consortium (interlymph). Cancer Epidemiol Biomarkers Prev 2005;14(4):925-33
   PubMed Web of Science ®Google Scholar
• Vajdic CM, Landgren O, McMaster ML, et al. Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/waldenstrom’s macroglobulinemia: the interlymph non-hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr 2014;2014(48):87-97
   PubMedGoogle Scholar
• Slager SL, Benavente Y, Blair A, et al. Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: the interlymph non-hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr 2014;2014(48):41-51
   PubMedGoogle Scholar
• Mbulaiteye SM, Morton LM, Sampson JN, et al. Medical history, lifestyle, family history, and occupational risk factors for sporadic burkitt lymphoma/leukemia: the interlymph non-hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr 2014;2014(48):106-14
   PubMedGoogle Scholar
• Linet MS, Vajdic CM, Morton LM, et al. Medical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the interlymph non-hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr 2014;2014(48):26-40
   PubMedGoogle Scholar
• Cerhan JR, Kricker A, Paltiel O, et al. Medical history, lifestyle, family history, and occupational risk factors for diffuse large b-cell lymphoma: the interlymph non-hodgkin lymphoma subtypes project. J Natil Cancer Inst Monogr 2014;2014(48):15-25
   PubMedGoogle Scholar
• Wang SS, Flowers CR, Kadin ME, et al. Medical history, lifestyle, family history, and occupational risk factors for peripheral t-cell lymphomas: the interlymph non-hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr 2014;2014(48):66-75
   PubMedGoogle Scholar
• Smedby KE, Sampson JN, Turner JJ, et al. Medical history, lifestyle, family history, and occupational risk factors for mantle cell lymphoma: the interlymph non-hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr 2014;2014(48):76-86
   PubMedGoogle Scholar
• Skibola CF, Slager SL, Berndt SI, et al. Medical history, lifestyle, family history, and occupational risk factors for adult acute lymphocytic leukemia: the interlymph non-hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr 2014;2014(48):125-9
   PubMedGoogle Scholar
• Morton LM, Sampson JN, Cerhan JR, et al. Rationale and design of the international lymphoma epidemiology consortium (interlymph) non-hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr 2014;2014(48):1-14
   PubMedGoogle Scholar
• Morton LM, Slager SL, Cerhan JR, et al. Etiologic heterogeneity among non-hodgkin lymphoma subtypes: the interlymph non-hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr 2014;2014(48):130-44
   PubMedGoogle Scholar
• Monnereau A, Slager SL, Hughes AM, et al. Medical history, lifestyle, and occupational risk factors for hairy cell leukemia: the interlymph non-hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr 2014;2014(48):115-24
   PubMedGoogle Scholar
• Bracci PM, Benavente Y, Turner JJ, et al. Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the interlymph non-hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr 2014;2014(48):52-65
   PubMedGoogle Scholar
• Aschebrook-Kilfoy B, Cocco P, La Vecchia C, et al. Medical history, lifestyle, family history, and occupational risk factors for mycosis fungoides and sezary syndrome: the interlymph non-hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr 2014;2014(48):98-105
   PubMedGoogle Scholar
• International Standard Classification of Occupations. Revised Edition. International Labour Office, Geveva. Switzerland; 1969
   Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21(11):1539-58
   PubMed Web of Science ®Google Scholar
• Swerdlow S, Campo E, Harris N, et al. WHO classification of Tumours of Haematopoietic and Lymphoid Tissues. (International Agency for Research on Cancer (IARC), Lyon, France; 2008
   Google Scholar
• Flowers CR, Sinha R, Vose JM. Improving outcomes for patients with diffuse large B-cell lymphoma. CA Cancer J Clin 2010;60(6):393-408
   PubMed Web of Science ®Google Scholar
• Cerhan JR, Berndt SI, Vijai J, et al. Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma. Nat Genet 2014;46(11):1233-8
   PubMed Web of Science ®Google Scholar
• Zhang J, Grubor V, Love CL, et al. Genetic heterogeneity of diffuse large B-cell lymphoma. Proc Natl Acad Sci USA 2013. 110(4):1398-403
   Google Scholar
• Love C, Sun Z, Jima D, et al. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet 2012;44(12):1321-5
   PubMed Web of Science ®Google Scholar
• Ambinder AJ, Shenoy PJ, Malik N, et al. Exploring risk factors for follicular lymphoma. Adv Hematol 2012;2012:626035
   PubMedGoogle Scholar
• Friedberg JW, Taylor MD, Cerhan JR, et al. Follicular lymphoma in the United States: first report of the national LymphoCare study. J Clin Oncol 2009;27(8):1202-8
   PubMed Web of Science ®Google Scholar
• Flowers CR, Armitage JO. A decade of progress in lymphoma: advances and continuing challenges. Clin Lymphoma Myeloma Leuk 2010;10(6):414-23
   PubMed Web of Science ®Google Scholar
• Wu SJ, Huang SY, Lin CT, et al. The incidence of chronic lymphocytic leukemia in Taiwan, 1986-2005: a distinct increasing trend with birth-cohort effect. Blood 2010;116(22):4430-5
   PubMed Web of Science ®Google Scholar
• Clarke CA, Glaser SL, Gomez SL, et al. Lymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturation. Cancer Epidemiol Biomarkers Prev 2011;20(6):1064-77
   PubMedGoogle Scholar
• Diaz LE, Montero A, Gonzalez-Gross M, et al. Influence of alcohol consumption on immunological status: a review. Eur J Clin Nutr 2002;56(Suppl 3):S50-3
   PubMed Web of Science ®Google Scholar
• Hickish T, Cunningham D, Colston K, et al. The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma. Br J Cancer 1993;68(4):668-72
   PubMed Web of Science ®Google Scholar
• Cerhan JR, Engels EA, Cozen W, et al. Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study. Int J Cancer 2008;123(4):888-94
   PubMedGoogle Scholar
• Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program 2009;523-31
   PubMedGoogle Scholar
• Abouyabis AN, Shenoy PJ, Lechowicz MJ, Flowers CR. Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States. Leuk Lymphoma 2008;49(11):2099-107
   PubMed Web of Science ®Google Scholar
• Flowers CR, Glover R, Lonial S, Brawley OW. Racial Differences in the incidence and outcomes for patients with hematological malignancies. Curr Probl Cancer 2007;31(3):182-201
   PubMedGoogle Scholar
• Flowers CR, Nastoupil LJ. Socioeconomic disparities in lymphoma. Blood 2014;123(23):3530-1
   PubMed Web of Science ®Google Scholar
• Flowers CR, Pro B. Racial differences in chronic lymphocytic leukemia. Digging deeper. Cancer 2013;119(20):3593-5
   PubMedGoogle Scholar
• Imam MH, Shenoy PJ, Flowers CR, et al. Incidence and survival patterns of cutaneous T-cell lymphomas in the United States. Leuk Lymphoma 2013;54(4):752-9
   PubMed Web of Science ®Google Scholar
• Shenoy PJ, Malik N, Nooka A, et al. Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer 2011;117(11):2530-40
   PubMed Web of Science ®Google Scholar
• Shenoy PJ, Malik N, Sinha R, et al. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the united States. Clin Lymphoma Myeloma Leuk 2011;11(6):498-506
   PubMed Web of Science ®Google Scholar
• Geyer SM, Morton LM, Habermann TM, et al. Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study. Cancer 2010;116(12):2993-3000
   PubMed Web of Science ®Google Scholar
• Simard JF, Baecklund F, Chang ET, et al. Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes. Int J Cancer 2013;132(11):2659-66
   PubMed Web of Science ®Google Scholar
• Ollberding NJ, Evens AM, Aschebrook-Kilfoy B, et al. Pre-diagnosis cigarette smoking and overall survival in non-Hodgkin lymphoma. Br J Haematol 2013;163(3):352-6
   PubMedGoogle Scholar
• Talamini R, Polesel J, Spina M, et al. The impact of tobacco smoking and alcohol drinking on survival of patients with non-Hodgkin lymphoma. Int J Cancer 2008;122(7):1624-9
   PubMedGoogle Scholar
• Battaglioli T, Gorini G, Costantini AS, et al. Cigarette smoking and alcohol consumption as determinants of survival in non-Hodgkin’s lymphoma: a population-based study. Ann Oncol 2006;17(8):1283-9
   PubMedGoogle Scholar
• Kelly JL, Drake MT, Fredericksen ZS, et al. Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma. Cancer Causes Control 2012;23(7):1017-29
   PubMedGoogle Scholar
• Lu D, Chen J, Jin J. Vitamin D status and risk of non-Hodgkin lymphoma: a meta-analysis. Cancer Causes Control 2014;25(11):1553-63
   PubMedGoogle Scholar
• Tretli S, Schwartz GG, Torjesen PA, Robsahm TE. Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control 2012;23(2):363-70
   PubMed Web of Science ®Google Scholar
• Shanafelt TD, Drake MT, Maurer MJ, et al. Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood 2011;117(5):1492-8
   PubMed Web of Science ®Google Scholar
• Drake MT, Maurer MJ, Link BK, et al. Vitamin D insufficiency and prognosis in non-Hodgkin’s lymphoma. J clin Oncol 2010;28(27):4191-8
   PubMed Web of Science ®Google Scholar
• Bittenbring JT, Neumann F, Altmann B, et al. Vitamin d deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab. J Clin Oncol 2014;32(29):3242-8
   PubMed Web of Science ®Google Scholar
• Cholecalciferol in improving survival in patients with newly diagnosed cancer with vitamin d insufficiency. Available from: https://clinicaltrials.gov/ct2/show/NCT01787409
   Google Scholar